在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Photosystem II protein Y (psbY), partial CSB-YP631301EXX
CSB-EP631301EXX
CSB-BP631301EXX
CSB-MP631301EXX
CSB-EP631301EXX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Photosystem I reaction center subunit IX (psaJ), partial CSB-YP631302EXX
CSB-EP631302EXX
CSB-BP631302EXX
CSB-MP631302EXX
CSB-EP631302EXX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Light-independent protochlorophyllide reductase iron-sulfur ATP-binding protein (chlL) CSB-YP631303EXX
CSB-EP631303EXX
CSB-BP631303EXX
CSB-MP631303EXX
CSB-EP631303EXX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Aspergillus oryzae Transcriptional activator hacA (hacA) CSB-YP631304DPA
CSB-EP631304DPA
CSB-BP631304DPA
CSB-MP631304DPA
CSB-EP631304DPA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Gorilla gorilla gorilla Agouti-signaling protein (ASIP) CSB-YP631305GGZ
CSB-EP631305GGZ
CSB-BP631305GGZ
CSB-MP631305GGZ
CSB-EP631305GGZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pan troglodytes Tripartite motif-containing protein 39 (TRIM39), partial CSB-YP631306EQV
CSB-EP631306EQV
CSB-BP631306EQV
CSB-MP631306EQV
CSB-EP631306EQV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pan troglodytes Uncharacterized protein C6orf15 homolog (STG) CSB-YP631307EQV
CSB-EP631307EQV
CSB-BP631307EQV
CSB-MP631307EQV
CSB-EP631307EQV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Cryptotis goldmani Cytochrome b (MT-CYB), partial CSB-YP631308CBAR
CSB-EP631308CBAR
CSB-BP631308CBAR
CSB-MP631308CBAR
CSB-EP631308CBAR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Soriculus nigrescens Cytochrome b (MT-CYB), partial CSB-YP631309SBAS
CSB-EP631309SBAS
CSB-BP631309SBAS
CSB-MP631309SBAS
CSB-EP631309SBAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Crocidura fuliginosa Cytochrome b (MT-CYB), partial CSB-YP631310CBAS
CSB-EP631310CBAS
CSB-BP631310CBAS
CSB-MP631310CBAS
CSB-EP631310CBAS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Frizzled/smoothened-like sans CRD protein F (fscF), partial CSB-YP631311DKK1
CSB-EP631311DKK1
CSB-BP631311DKK1
CSB-MP631311DKK1
CSB-EP631311DKK1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Ubiquitin-fold modifier-conjugating enzyme 1 (ufc1) CSB-YP631312DKK
CSB-EP631312DKK
CSB-BP631312DKK
CSB-MP631312DKK
CSB-EP631312DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum PH domain-containing protein DDB_G0287875 (DDB_G0287875), partial CSB-YP631313DKK
CSB-EP631313DKK
CSB-BP631313DKK
CSB-MP631313DKK
CSB-EP631313DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Proliferation-associated protein A (prlA) CSB-YP631314DKK
CSB-EP631314DKK
CSB-BP631314DKK
CSB-MP631314DKK
CSB-EP631314DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum DNA mismatch repair protein Msh3 (msh3), partial CSB-YP631315DKK
CSB-EP631315DKK
CSB-BP631315DKK
CSB-MP631315DKK
CSB-EP631315DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Probable serine/threonine-protein kinase DDB_G0278845 (DDB_G0278845), partial CSB-YP631316DKK
CSB-EP631316DKK
CSB-BP631316DKK
CSB-MP631316DKK
CSB-EP631316DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Formin-G (forG), partial CSB-YP631317DKK
CSB-EP631317DKK
CSB-BP631317DKK
CSB-MP631317DKK
CSB-EP631317DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyostelium discoideum Fumarylacetoacetase (fah) CSB-YP631318DKK
CSB-EP631318DKK
CSB-BP631318DKK
CSB-MP631318DKK
CSB-EP631318DKK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Deinagkistrodon acutus Phospholipase A2, basic isoform CSB-YP631319DIX
CSB-EP631319DIX
CSB-BP631319DIX
CSB-MP631319DIX
CSB-EP631319DIX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Probable rhamnogalacturonase E (rhgE) CSB-YP631320DOZ
CSB-EP631320DOZ
CSB-BP631320DOZ
CSB-MP631320DOZ
CSB-EP631320DOZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.51tesewang.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>